semaglutide injection sites Sites: Abdomen vs. Thigh – Which Is Better? Is There a Best Place

Metabolites produced by the gut microbiota, such as short-chain fatty acids (SCFAs), play a crucial role in maintaining intestinal health

From suppressing thirst signals to slowing gastric emptying, from increasing the risk of gastrointestinal fluid losses to potentially affecting kidney function, these medications create a complex web of hydration challenges that require proactive management.The good news is that with proper knowledge, evidence-based strategies, and the right hydration solutions, these challenges are entirely manageable

Releasing Q2 earnings on Monday, Hims & Hers Co-Founder and CEO Andrew Dudem said users of its personalized GLP-1 treatment plans had lost an average 10.3% of their body weight over six months, and that only 25% of them had discontinued treatment, particularly encouraging when considering discontinuation rates in certain publicly available studies reached approximately 80% percent by six months. Saying that personalized treatments allow patients to receive clear treatment instructions and educational content while also accessing tools such as water intake trackers and calorie counters, Dudem complained of pushback from traditional incumbents. During its own earnings call on Wednesday, Novo Nordisk doubled down against GLP-1 compounders that it says are still around despite the end of an FDA-granted grace period in May

Growth Hormone Research Society Workshop Summary: Consensus guidelines for recombinant human growth hormone therapy in critically ill adults. Crit Care Med

The conversion charts on our site go into much greater detail on this topic

Is Sulfur Burps a Reason to Stop GLP-1 Treatment Sulfur burps alone are rarely severe enough to warrant discontinuing GLP-1 therapy, especially when weighed against the significant weight loss and metabolic benefits these medications deliver